Overview

Aspirin Resistance Reversibility in Diabetic Patients

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.
Phase:
Phase 4
Details
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Treatments:
Acetylsalicylic acid lysinate
Aspirin